v3.24.2.u1
Stockholders' Equity (Tables)
 6 Months Ended
Jun. 30, 2024
Equity [Abstract]  
Schedule of Stock Option Activity
Stock option activity for the six months ended June 30, 2024 is presented below:
Outstanding optionsWeighted average exercise priceWeighted average remaining contractual term (years)Aggregate intrinsic value (thousands)
Balance as of December 31, 202312,318,335 $12.06 5.4$2,845 
Canceled(679,660)10.73 
Balance as of June 30, 202411,638,675 12.14 5.015 
Vested and exercisable as of June 30, 202410,420,075 12.19 4.615 
Vested and expected to vest as of June 30, 202411,577,687 $12.15 4.9$15 
Schedule of Restricted Stock Activity
Stock award activity, which includes RSUs, PSUs and restricted stock awards (RSAs), for the six months ended June 30, 2024 is presented below:
Outstanding RSUs, RSAs and PSUsWeighted-average grant date fair value per shareWeighted average remaining contractual term (years)Aggregate intrinsic value (thousands)
Balance as of December 31, 202312,478,798 $9.40 1.2$104,315 
Awarded7,115,594 5.38 
Released(2,745,448)9.69 
Canceled(901,888)9.33 
Balance as of June 30, 202415,947,056 7.57 1.277,184
Vested and expected to vest as of June 30, 202414,735,803 $7.58 1.2$71,321 
Schedule of Stock-Based Compensation Expense
Stock-based compensation expense recognized in connection with stock options, RSUs, RSAs, PSUs and the Employee Stock Purchase Plan (ESPP) during each of the three and six months ended June 30, 2024 and 2023 was as follows (in thousands):

Three Months Ended June 30,Six Months Ended June 30,

2024202320242023
Cost of net revenue$128 $226 $279 $423 
Product development7,060 5,184 13,034 9,508 
Sales, marketing and support1,850 2,792 4,284 5,020 
General and administrative6,238 6,397 11,641 11,742 
      Total$15,276 $14,599 $29,238 $26,693